Biomarker types and colorectal cancer
Biomarkers 101
Learn the basics about biomarkers and colorectal cancer, why testing is important, and what learning about your biomarker mutations can mean for your treatment options and cancer outcomes.
Biomarker type resource guide
This resource grid details the different types of biomarkers and how they relate to a colorectal cancer diagnosis and treatment.
The Alliance’s personalized treatment program
The Alliance and Perthera have partnered to provide personalized treatment options to stage III and IV patients with colorectal cancer.
If you recently had molecular/biomarker testing, your results will be analyzed with no additional testing required.
Call us at the Alliance’s Helpline at (877) 422-2030 to enroll.
Related reading
SidednessTop resources
Meredith’s legacy: A family’s mission to save lives
After losing their sister Meredith to colorectal cancer, Kathryn and Abigail are turning grief into advocacy. Their powerful story highlights the urgent need for CRC awareness and action — especially among young adults who are facing rising rates of this disease.
Alliance Reaches Out To Hispanic Population With Latest PSA
The nation’s leading nonprofit dedicated to ending colorectal cancer has launched Preventable, a new public service announcement, in Spanish and English. Watch it now.
Statement: SCOTUS Decision in Kennedy v. Braidwood Management, Inc.
The Colorectal Cancer Alliance applauds the Supreme Court’s decision in Kennedy v. Braidwood, preserving no-cost preventive care under the ACA—including lifesaving colorectal cancer screenings.